The psychiatrist mentioned ketamine at the last medication check, and everyone left the appointment with more questions than answers. Is this the same drug from news stories about clinics and parties? Why would a doctor recommend something that sounds experimental when the only goal is for the depression to finally lift? Maybe you were the patient in that room. Maybe you were the spouse, the parent, or the adult child sitting in the chair by the door, holding the car keys and the medication list. Either way, those are fair questions. You deserve straight answers before anyone places an IV in an arm or hands over a nasal spray. This guide explains what ketamine treatment for depression actually is, and when a psychiatrist recommends it. It is written from inside Florida Oasis Residential Mental Health in Lake Park, FL, a program capped at nine clients where an onsite board-certified psychiatrist directs every case.
Picture the drive home from that appointment. The radio is off. You are running the same numbers you have run before. The first antidepressant made them feel flat. The second did nothing. The third stopped because of side effects. Each time, everyone waited six weeks to find out if this one would be different. Each time, you watched the person you love disappear a little further into survival mode. Now a new word is on the table, and it comes with headlines attached.
Here is the honest version. Ketamine is not a party drug in a white coat, and it is not a miracle. It is a serious medical tool with a specific job. Used well, it can open a door that years of other treatment could not, though individual responses vary and some people experience little or no benefit. Used carelessly, it becomes one more thing that did not work. And if you are the one who has been making the calls, filling the prescriptions, and lying awake listening for footsteps, you already know how heavy “one more thing” can feel.
One practical note before we go further, because it is usually the first worry on a family’s mind: Florida Oasis accepts BCBS, Cigna, Aetna, UnitedHealthcare, Ambetter, and Magellan. Our admissions team can check benefits for residential mental health care before anyone has to decide anything.
The Short Answer: What Ketamine Treatment for Depression Actually Is, and When a Psychiatrist Recommends It
Ketamine treatment for depression is the medically supervised use of low doses of ketamine, or its close relative esketamine, to relieve major depression that has not improved with standard antidepressants, often called treatment-resistant depression. A psychiatrist recommends it after at least two adequate medication trials have failed, and only when the treatment can be given, monitored, and followed up safely.
Ketamine was first developed as an anesthetic. It has been used in operating rooms and emergency medicine for decades. The doses used for depression are far lower than the doses used for surgery. They are given slowly, in a clinical setting, while a medical team watches blood pressure, heart rate, and breathing the whole time. That is a world away from the recreational use you read about in the news. The researchers who helped discover ketamine’s fast effect on depression have been just as clear about the risks. They have urged clinicians to handle ketamine with care, because the same drug that can help can also be misused once the guardrails come off.
So ketamine is not first-line care. Nobody starts here. Psychiatrists consider it later, alongside options like TMS and ECT, for people whose depression has outlasted the usual tools. Florida Oasis coordinates four of these advanced treatments: ketamine infusions, Spravato treatments, TMS, and ECT. They sit inside a wider psychiatric plan that also includes psychotropic medication adjustment, intensive personalized therapy, and EMDR.
That wider plan matters more than it sounds. A good psychiatrist is not only asking, “Could ketamine help?” The better question is, “Is this the right time, the right setting, and the right support around it?” At Florida Oasis we put it simply: we have to be the right place, not just an open bed. For a closer look at how this works inside a residential program, read our overview of ketamine treatment for depression in residential care.
How Does Ketamine Work Differently Than the Antidepressants You Already Tried?
Most antidepressants, including SSRIs and SNRIs, adjust serotonin and norepinephrine, and they usually take four to six weeks to show an effect. Ketamine works on a different system: glutamate, the brain’s main “go” signal. By blocking NMDA receptors, it sets off a chain reaction that may help brain cells grow new connections. That is why some people feel a shift within hours or days, though the timing and degree of response varies considerably from person to person.
Think about what long-term depression does to the brain. When a person lives in survival mode for months or years, stress keeps washing over the brain regions that handle mood, focus, and decisions. Over time, the connections between brain cells in those areas, called synapses, can thin out. Picture a road network where bridges slowly close. Traffic still moves, but every trip takes longer, and some places become hard to reach at all. That is part of why depression can feel like thinking through mud, and why the person you love may seem to answer every question from very far away.
SSRIs and SNRIs try to improve that traffic by raising the levels of certain chemical messengers. For many people, that works. For others, especially after several failed trials, it barely moves the needle, and their depression may be described as treatment-resistant. Ketamine takes another route. When it blocks NMDA receptors, the brain may respond with a short burst of glutamate activity. That burst can trigger growth signals, including a protein called BDNF, that may help rebuild synapses. Scientists call this synaptogenesis, which simply means “making new connections.” The National Institute of Mental Health has supported years of research into this glutamate pathway, because it offered something older drugs did not: a fast-acting option for people those drugs had left behind.
Here is what that means in real life. Ketamine may open a short window where the brain is more flexible than it has been in a long time for some patients. Stuck patterns of thinking can loosen. But a window is not a new house. What happens inside that window helps decide whether the change holds: the therapy, the sleep, the steady relationships, and the practice of new ways of thinking. At Florida Oasis, that window lands inside a week that already holds two individual therapy sessions and more than 40 hours of group programming. Ketamine is never a standalone event here. It is timed to sit inside the deep work of recovery, not apart from it.
What Is Treatment-Resistant Depression, and Does It Mean You Qualify for Ketamine?
Treatment-resistant depression is major depressive disorder that has not responded well enough to at least two different antidepressants, each taken at a proper dose for a long enough time. Meeting that bar makes a person eligible for a conversation about ketamine. It does not, on its own, make them a good candidate.
The definition sounds simple, but the details matter. An adequate trial usually means taking a medication at a therapeutic dose, consistently, for several weeks, often six to eight. A medication someone stopped after ten days because of nausea may not count. A dose that was never raised into the effective range may not count either. A published health technology review of ketamine focuses on adults whose depression has not responded to standard treatment. That is the group psychiatrists have in mind when ketamine comes up.
At Florida Oasis, the onsite board-certified psychiatrist completes a full psychiatric assessment before deciding whether ketamine belongs in the plan. It covers several areas:
- Medication history: every antidepressant, the dose, how long it was taken, whether it was taken daily, and why it stopped.
- Standardized measures: validated depression questionnaires (the PHQ-9 is one widely used example), so symptoms have a clear, measurable starting point instead of a vague impression.
- Trauma: depression that sits on top of unprocessed trauma often needs trauma work, such as EMDR, in addition to medication.
- Substance use: alcohol or drug use can drive depression, and ketamine itself carries a risk of misuse.
- Medical review: baseline vital signs and health history, since ketamine raises blood pressure for a short time and is not safe with certain heart, blood vessel, or brain conditions.
The psychiatrist is also looking for what might be hiding behind the label. Sometimes depression is not resisting treatment. Sometimes the right problem was never treated. Untreated trauma, ongoing substance use, poor sleep, or a medical issue can keep depression in place no matter which pill a person takes. Reality testing the diagnosis comes before reaching for a stronger tool.
There is one more piece, and we want to say it plainly. Florida Oasis is a house of nine, and everyone in it needs to be stable enough to live and heal in a community that small. Someone with active psychosis who needs a secure unit, or someone with high-intent suicidal thoughts who needs round-the-clock line-of-sight monitoring, needs hospital-level care first. We also do not accept involuntary holds under the Baker Act. That is not a rejection. It is a promise to point your family toward the place that can keep your loved one safe right now, so that when residential work begins, the timing is right.
Which Is Right for You: IV Ketamine or Esketamine (Spravato)?
The two main forms of ketamine treatment for depression are intravenous (IV) ketamine, given through a vein and used off-label, and esketamine nasal spray, sold as Spravato, which the FDA has approved for adults with treatment-resistant depression. Both require medical supervision. They differ in how they are given, how they are regulated, and how insurance tends to treat them.
| Feature | IV ketamine infusion | Esketamine nasal spray (Spravato) |
|---|---|---|
| FDA status | Off-label for depression (FDA approved as an anesthetic) | FDA approved for treatment-resistant depression in adults |
| How it is given | Slow drip through a vein | Nasal spray the patient gives themselves under direct medical observation |
| Typical session | About 40 minutes of infusion, then monitored recovery | Doses a few minutes apart, then at least 2 hours of monitoring |
| Starting schedule | Often 6 infusions over 2 to 3 weeks | Twice weekly for weeks 1 to 4, then weekly for weeks 5 to 8 |
| Ongoing schedule | Spaced maintenance infusions set by the psychiatrist | Weekly or every other week after week 8 |
| Where it happens | Clinical setting with vital sign monitoring | Certified healthcare setting enrolled in a federal safety program (REMS) |
| Insurance | Coverage is often limited because use is off-label | Coverage is more common, usually with prior authorization |
Esketamine is one of the two mirror-image halves of the ketamine molecule. IV ketamine lets the medical team set and adjust the dose precisely, minute by minute. Spravato brings a fixed, FDA-approved structure, a defined safety program, and a clearer path through insurance. Neither is automatically better. The right choice depends on medical history, blood pressure, reactions to past treatments, insurance, and what the person feels ready to try.
Recent research keeps adding to the picture. A large 2023 trial, reported in this university news story, found that in one study of adults with treatment-resistant depression without psychosis, IV ketamine showed similar effectiveness to ECT. That finding matters because it gives psychiatrists a real choice, not a last resort. Because Florida Oasis coordinates ketamine infusions, Spravato treatments, TMS, and ECT, your psychiatrist can weigh all four options against your actual history instead of steering you toward whichever one happens to be down the hall.
What Actually Happens During a Ketamine Infusion, and Who Is With You Afterward?
A ketamine infusion session usually takes about two hours from check-in to medical release: vital signs, a slow 40-minute infusion, a monitored recovery, and a final check. At Florida Oasis, the part that matters most comes after, because the resident returns to a team of people who already know them by name and know they had a session today.
- Psychiatric clearance. Before each session, the psychiatrist reviews sleep, appetite, mood, and current medications and confirms the treatment still makes sense. If blood pressure has been running high or something has shifted, the session can wait.
- Simple preparation. The patient may be asked not to eat for a few hours beforehand, which lowers the chance of nausea. Comfortable clothes help. Some people bring headphones with calm music or an eye mask.
- Baseline vital signs. On arrival, the medical team measures blood pressure, heart rate, and oxygen level, then places a small IV line in the arm.
- The infusion. The most common protocol for depression is 0.5 mg of ketamine per kilogram of body weight, given slowly over about 40 minutes. Within minutes, many people feel light, floaty, or a little detached from their body. Sounds may seem far away and time may stretch. Some people feel calm. Others feel emotions or memories rise to the surface. This is called dissociation, and it is expected.
- Continuous monitoring. A clinician stays with the patient, rechecks vital signs, and can slow or stop the infusion if needed.
- Recovery. After the drip ends, the dissociative effects usually fade within an hour or so. The patient rests until they feel steady and clear-headed, and until vital signs are back near the starting point.
- Medical release. No one leaves until the team is satisfied. The patient should not drive for the rest of the day.
- Return to the program. Instead of going home to an empty apartment, the resident comes back to a house of no more than nine people, where staff are expecting them.
- Integration. Over the next days, the individual therapist helps make sense of what came up, the psychiatrist tracks the response, and group programming gives a place to practice new ways of thinking while the brain may be more flexible for some patients.
Spravato sessions follow a similar shape. The main differences are that the patient gives themselves the nasal spray while a clinician watches, and the monitoring period lasts at least two hours.
Now picture the standalone version, because many families have lived it. Someone gets the infusion at a clinic, a relative drives them home after the monitoring period, and the next therapy appointment is a week away. If a painful memory surfaces that night, they meet it alone, with a nervous system that is wide open and nobody in the room who knows what to do. No one should be a barcode in a moment like that. Neither should the person you love.
Here is how that same night can look in residential care. Consider one illustrative example: a father in his fifties who, after his third infusion, finds a memory he has avoided for twenty years coming back hard that evening. This is a single scenario, not a typical result; what surfaces during treatment varies widely, and some patients experience little emotional shift. He does not have to call his wife from a parking lot. Staff who know him are in the house that night. His therapist can see him at his next scheduled session that week, and because he has two individual sessions every week, that is days away, not a full week. If trauma is driving the depression, EMDR can become part of his plan with a clinician who already knows his history.
Florida Oasis is built this way on purpose. Residents receive two individual therapy sessions per week, double the industry standard, plus more than 40 hours of group programming every week. Steady, calm staff also offer something harder to name: co-regulation, the way a settled person nearby can help an unsettled nervous system find its footing. Care here is relational, not transactional. The goal is to catch you before you fall, not to read about it in a voicemail days later.
How Quickly Can Ketamine Lift Depression, and Why Does One Session Not Settle It?
Some people notice their mood lift within hours to a day of their first ketamine treatment, far faster than the four to six weeks oral antidepressants usually need, though other patients may feel little change or may experience only partial improvement. That early lift often fades, which is why a standard course uses repeated sessions, most often six infusions over two to three weeks, followed by maintenance.
A systematic review of ketamine for major depression describes this pattern: antidepressant effects that can appear quickly in some patients but tend to wear off without continued treatment. That can be confusing if nobody warns you. Picture one hypothetical patient, not a typical result: a woman in her thirties, years into failed medications, who laughs at dinner for the first time in months after her first session, though response timing and degree vary widely and many patients feel little change early on. Two days later the fog drifts back, and her mother is frightened that it has already failed. It has not. It is simply early. This is exactly the pattern the research predicts, and it is why the psychiatrist watches the trend across the whole course rather than judging any single day.
Repeated sessions matter because the brain changes may build on each other in patients who respond. Each treatment may add to the new connections the last one started. For IV ketamine, that usually means six infusions over two to three weeks. For Spravato, it means twice-weekly sessions for the first four weeks, then weekly sessions for the next four. After that first course, many people need maintenance treatment, spaced out over time, to hold the benefit. The psychiatrist sets that spacing based on how the person responds, not on a fixed calendar.
It is also important to say this plainly: not everyone responds to ketamine. Some people feel a strong, lasting change. Some feel a partial change. Some feel little at all. A responsible program measures rather than guesses. Florida Oasis tracks progress with standardized measures and publishes its outcome data, so progress is something you can see. If ketamine is helping, the scores should show it. If it is not, the psychiatrist can change course, toward TMS, ECT, or a medication adjustment, without wasting months.
Because maintenance sessions often continue after a residential stay ends, ask early in treatment who will provide them and how records will be shared, so the progress made does not stall in a gap between appointments.
What Are the Side Effects and Risks of Ketamine Therapy for Depression?
The most common side effects of ketamine therapy for depression are dissociation, dizziness, nausea, sleepiness, and a short-term rise in blood pressure, and most fade within a couple of hours. More serious risks, including misuse and danger for people with certain heart, blood vessel, or psychotic conditions, are why ketamine belongs only in medically supervised care.
- Dissociation: feeling detached from the body or surroundings, with changes in how a person senses time, sound, or sight. It usually passes within an hour or two after the dose ends.
- Raised blood pressure and heart rate: a temporary increase during and shortly after treatment, which is why vital signs are checked before, during, and after every session.
- Nausea and vomiting: common during or after a session, and often eased by not eating for a few hours beforehand.
- Dizziness, sleepiness, and poor coordination: reasons not to drive or operate machinery for the rest of the day. After Spravato, patients should not drive until the next day, after restful sleep.
- Headache, blurred vision, or anxiety during the session: usually short-lived and managed by the monitoring team.
- Brief confusion or mental fog: typically clears the same day.
- Misuse and dependence: ketamine is a controlled substance with real potential for misuse. This is a key reason no one should be using it at home without monitoring.
- Bladder and urinary problems: linked mainly to heavy, frequent recreational use, not supervised treatment doses, but worth knowing about.
- Conditions that may rule it out: uncontrolled high blood pressure, aneurysm or other blood vessel disease, a history of bleeding in the brain, active psychosis, and pregnancy all call for careful review, and some make ketamine unsafe.
Safety comes from the setting as much as the drug. At Florida Oasis, the onsite board-certified psychiatrist directs every case, starting with baseline vital signs and continuing with monitoring throughout treatment. The census never goes above nine clients at a time, and we protect that number fiercely. A small census means the team notices the quiet changes: the resident who skipped breakfast, the one who seems more withdrawn after a session, the one whose blood pressure crept up overnight. In a large program, those signs can get lost. In a house of nine, they are hard to miss.
If something difficult comes up, the response is immediate. The therapist is already on that resident’s schedule twice that week. The psychiatrist is onsite and can adjust medication or pause the ketamine schedule. Peers and staff form a steady container around the resident while they work through it. The clinical expertise of a hospital. The heart and comfort of a home. That is not a slogan here. It is the safety plan.
Is Ketamine for Depression FDA Approved, and What Else Should You Ask?
Esketamine nasal spray (Spravato) is FDA approved for adults with treatment-resistant depression, while IV ketamine is used off-label for depression under medical supervision. Here are clear answers to the other questions people most often bring to their first call.
Is ketamine for depression FDA approved?
Spravato, a form of esketamine, has FDA approval for treatment-resistant depression in adults and must be given in a certified healthcare setting with at least two hours of monitoring. IV ketamine is FDA approved as an anesthetic. Its use for depression is off-label, which is legal and common in medicine, but it means insurance coverage and protocols can vary.
How many ketamine treatments are needed for depression?
A typical starting course is six IV infusions over two to three weeks, or twice-weekly Spravato sessions for the first four weeks, followed by weekly sessions. Most people who respond need maintenance sessions afterward to sustain the benefit, though duration and frequency vary by individual. The psychiatrist adjusts the plan based on scores and how the person feels.
Can someone do ketamine treatment while in residential mental health care?
Yes. Florida Oasis coordinates ketamine infusions and Spravato treatments within its residential mental health program. Treatment is woven into two individual therapy sessions per week, more than 40 hours of weekly group programming, psychotropic medication adjustment, and psychiatric oversight, so no one is managing it alone.
What does a psychiatrist assess before recommending ketamine for depression?
A psychiatrist reviews the full medication history, uses standardized depression measures, assesses trauma and substance use history, checks baseline vital signs and medical risks, and looks for other factors that may need attention first. At Florida Oasis, that assessment is done by the onsite board-certified psychiatrist who directs every case.
What are the risks of ketamine treatment for depression?
Risks include dissociation, raised blood pressure, nausea, dizziness, and potential for misuse. Medical supervision, cardiovascular monitoring, careful screening, and close follow-up through therapy reduce these risks.
What Should You Do If Your Psychiatrist Has Raised Ketamine?
Start with a full psychiatric assessment from a team that can see the whole picture, not only the medication history. Ketamine works best when it is part of a plan that also addresses trauma, sleep, substance use, and the daily support a person needs while the brain is changing.
If you are the family member reading this, you may be carrying fears you have not said out loud yet. What if they refuse to go, or leave after three days? How is this different from the last two programs that did not work? Can we even afford this? Those fears make sense. You have earned them. Here is what we can tell you honestly. Residential care here is voluntary, and we never pressure anyone. What we offer is a first conversation with someone who listens, and a small, steady house where the person you love is known by name instead of processed as a number. The difference from the last program is not a promise. It is the structure: no more than nine residents, a board-certified psychiatrist on site, two individual therapy sessions a week instead of one, more than 40 hours of group programming, and published outcome data you can read for yourself.
The insurance question deserves a straight answer too. Florida Oasis accepts BCBS, Cigna, Aetna, UnitedHealthcare, Ambetter, and Magellan. Coverage for the ketamine or Spravato treatment itself can differ from coverage for residential care, so the admissions team can help verify specific benefits before your family decides anything. Florida Oasis is located in Lake Park, FL, in a home-like residential setting with a maximum of nine clients.
Healing begins with respect, dignity, and a team that knows your name. If you or a family member is struggling with depression that has not responded to multiple medication trials, sometimes called treatment-resistant depression, call Florida Oasis at the number on this page. An admissions specialist can talk with you about a psychiatric assessment and whether ketamine treatment could be appropriate as part of a comprehensive residential care plan. Understanding what ketamine treatment for depression actually is, and when a psychiatrist recommends it, is the first step. The second is a phone call, and you do not have to make it with everything figured out.
One concrete thing to do before you call: write down every antidepressant that has been tried, the highest dose reached, how long it was taken, and why it stopped. That single page is often the most useful document a psychiatrist can see. It is the difference between “we tried everything” and a clear picture of what has actually been tried, and it is often the moment a tired family realizes there are still real options left, from ketamine and Spravato to TMS and ECT.
FDA Off-Label Use Disclosure: Spravato (esketamine) is FDA-approved for treatment-resistant depression. Ketamine for other uses is prescribed off-label (outside its original FDA approval) based on clinical judgment. Talk with your medical team to understand whether this treatment is right for you.
Ready to explore whether ketamine treatment might be right for you?
If you’ve been wondering whether this approach could help where other treatments haven’t, the team at Florida Oasis in Lake Park, FL is here to answer your questions. A conversation with our psychiatrists can help you understand your options and what to expect from treatment. Reach out today to discuss your unique situation and take the next step toward relief.
- This article is for general education and is not medical advice.
- Ketamine and esketamine treatment decisions should be made with a licensed psychiatrist who knows your full history.
- Treatment response varies from person to person.
- Scenarios described in this article are illustrative composites, not individual client accounts.
- If you are thinking about harming yourself or are in immediate danger, call or text 988 to reach the Suicide and Crisis Lifeline, or go to your nearest emergency room.
The post What Ketamine Treatment for Depression Actually Is, and When a Psychiatrist Recommends It appeared first on Florida Oasis Mental Health Center.